 Kenneth Hurt
Concepts (141)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nitric Oxide Synthase Type I | 4 | 2020 | 26 | 1.430 |
Why?
| | Parturition | 2 | 2019 | 56 | 1.160 |
Why?
| | Leptin | 2 | 2020 | 211 | 0.770 |
Why?
| | Penile Erection | 2 | 2012 | 6 | 0.700 |
Why?
| | Gasotransmitters | 1 | 2019 | 1 | 0.690 |
Why?
| | Fertilization | 1 | 2019 | 41 | 0.670 |
Why?
| | Cesarean Section | 2 | 2018 | 169 | 0.660 |
Why?
| | Ovary | 1 | 2020 | 190 | 0.640 |
Why?
| | Budd-Chiari Syndrome | 1 | 2018 | 8 | 0.640 |
Why?
| | Hypothalamo-Hypophyseal System | 1 | 2020 | 197 | 0.640 |
Why?
| | Dysarthria | 1 | 2018 | 9 | 0.630 |
Why?
| | Pregnancy Complications, Neoplastic | 1 | 2018 | 50 | 0.610 |
Why?
| | Parity | 1 | 2018 | 99 | 0.600 |
Why?
| | Labor, Obstetric | 1 | 2018 | 53 | 0.590 |
Why?
| | Nurse Midwives | 1 | 2018 | 29 | 0.590 |
Why?
| | Prenatal Diagnosis | 1 | 2018 | 167 | 0.560 |
Why?
| | Pregnancy, Abdominal | 1 | 2016 | 3 | 0.550 |
Why?
| | Obstetric Labor Complications | 1 | 2015 | 31 | 0.530 |
Why?
| | Methotrexate | 1 | 2016 | 228 | 0.500 |
Why?
| | Penis | 3 | 2012 | 37 | 0.470 |
Why?
| | Obstetrics | 1 | 2016 | 161 | 0.470 |
Why?
| | Education, Medical, Undergraduate | 1 | 2016 | 179 | 0.450 |
Why?
| | Students, Medical | 1 | 2016 | 280 | 0.400 |
Why?
| | Cyclic AMP | 1 | 2012 | 227 | 0.400 |
Why?
| | Uterus | 3 | 2019 | 193 | 0.400 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2012 | 132 | 0.400 |
Why?
| | Pancreatic Neoplasms | 1 | 2018 | 721 | 0.390 |
Why?
| | Pregnancy Complications | 1 | 2015 | 431 | 0.380 |
Why?
| | Communication | 1 | 2016 | 749 | 0.370 |
Why?
| | Physicians | 1 | 2018 | 774 | 0.340 |
Why?
| | Pregnancy | 6 | 2019 | 5555 | 0.340 |
Why?
| | Myometrium | 2 | 2019 | 35 | 0.290 |
Why?
| | Alternative Splicing | 1 | 2006 | 186 | 0.240 |
Why?
| | Obesity | 1 | 2015 | 2530 | 0.220 |
Why?
| | Mice, Inbred C57BL | 5 | 2020 | 4767 | 0.220 |
Why?
| | Phosphorylation | 2 | 2020 | 1561 | 0.210 |
Why?
| | Nitric Oxide | 2 | 2019 | 834 | 0.190 |
Why?
| | Genes, Transgenic, Suicide | 1 | 2020 | 8 | 0.180 |
Why?
| | Liver | 2 | 2019 | 1693 | 0.170 |
Why?
| | Pituitary Gland | 1 | 2020 | 152 | 0.170 |
Why?
| | Placentation | 1 | 2019 | 40 | 0.170 |
Why?
| | Cervix Uteri | 1 | 2019 | 44 | 0.170 |
Why?
| | Carbon Monoxide | 1 | 2019 | 68 | 0.170 |
Why?
| | Betaine-Homocysteine S-Methyltransferase | 1 | 2019 | 11 | 0.170 |
Why?
| | Placental Circulation | 1 | 2019 | 56 | 0.160 |
Why?
| | Hydrogen Sulfide | 1 | 2019 | 40 | 0.160 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2020 | 274 | 0.160 |
Why?
| | Electric Stimulation | 2 | 2012 | 263 | 0.160 |
Why?
| | Betaine | 1 | 2019 | 63 | 0.160 |
Why?
| | Taurine | 1 | 2019 | 41 | 0.160 |
Why?
| | Female | 8 | 2020 | 60081 | 0.160 |
Why?
| | Mice | 7 | 2020 | 15073 | 0.160 |
Why?
| | Extraction, Obstetrical | 1 | 2018 | 1 | 0.160 |
Why?
| | Homocystinuria | 1 | 2019 | 62 | 0.160 |
Why?
| | Prostaglandins | 2 | 2015 | 78 | 0.160 |
Why?
| | Mice, Knockout | 4 | 2019 | 2607 | 0.150 |
Why?
| | Animals | 9 | 2020 | 32122 | 0.150 |
Why?
| | Tomography, X-Ray Computed | 2 | 2018 | 2409 | 0.150 |
Why?
| | Oxytocin | 1 | 2018 | 45 | 0.150 |
Why?
| | Hemoperitoneum | 1 | 2016 | 13 | 0.140 |
Why?
| | Amino Acid Sequence | 1 | 2020 | 2000 | 0.130 |
Why?
| | Ligaments | 1 | 2016 | 44 | 0.130 |
Why?
| | Pregnancy, Ectopic | 1 | 2016 | 53 | 0.130 |
Why?
| | Dystocia | 1 | 2015 | 9 | 0.130 |
Why?
| | Uterine Contraction | 1 | 2015 | 17 | 0.130 |
Why?
| | Injections, Intramuscular | 1 | 2016 | 118 | 0.130 |
Why?
| | Delayed Diagnosis | 1 | 2016 | 72 | 0.130 |
Why?
| | Receptors, Oxytocin | 1 | 2015 | 22 | 0.130 |
Why?
| | Adipokines | 1 | 2015 | 43 | 0.130 |
Why?
| | Women's Health | 1 | 2018 | 271 | 0.130 |
Why?
| | Postpartum Period | 1 | 2018 | 281 | 0.130 |
Why?
| | Video Recording | 1 | 2016 | 147 | 0.130 |
Why?
| | Cyclooxygenase 2 | 1 | 2016 | 165 | 0.130 |
Why?
| | Observer Variation | 1 | 2016 | 299 | 0.130 |
Why?
| | Clinical Clerkship | 1 | 2016 | 75 | 0.130 |
Why?
| | Pelvis | 1 | 2016 | 92 | 0.130 |
Why?
| | Endotoxemia | 1 | 2016 | 84 | 0.130 |
Why?
| | Abdominal Pain | 1 | 2016 | 137 | 0.120 |
Why?
| | Fetal Diseases | 1 | 2016 | 148 | 0.120 |
Why?
| | Signal Transduction | 2 | 2019 | 4526 | 0.120 |
Why?
| | Infant, Newborn, Diseases | 1 | 2016 | 103 | 0.120 |
Why?
| | Biopsy | 1 | 2018 | 1056 | 0.120 |
Why?
| | Vagina | 1 | 2016 | 148 | 0.120 |
Why?
| | Spleen | 1 | 2016 | 491 | 0.120 |
Why?
| | Models, Animal | 1 | 2016 | 350 | 0.120 |
Why?
| | Educational Measurement | 1 | 2016 | 264 | 0.120 |
Why?
| | Cholesterol | 1 | 2015 | 367 | 0.120 |
Why?
| | Dinitrobenzenes | 1 | 2013 | 6 | 0.120 |
Why?
| | Priapism | 1 | 2013 | 10 | 0.110 |
Why?
| | Rats, Sprague-Dawley | 3 | 2016 | 2262 | 0.110 |
Why?
| | Humans | 10 | 2019 | 115901 | 0.110 |
Why?
| | Databases, Factual | 1 | 2018 | 1149 | 0.110 |
Why?
| | Rats | 4 | 2016 | 5035 | 0.110 |
Why?
| | Colforsin | 1 | 2012 | 46 | 0.110 |
Why?
| | Logistic Models | 1 | 2018 | 1865 | 0.110 |
Why?
| | NG-Nitroarginine Methyl Ester | 1 | 2012 | 38 | 0.110 |
Why?
| | Psychometrics | 1 | 2016 | 617 | 0.110 |
Why?
| | Ultrasonography | 1 | 2016 | 671 | 0.100 |
Why?
| | Serine | 1 | 2012 | 125 | 0.100 |
Why?
| | Laparoscopy | 1 | 2016 | 400 | 0.100 |
Why?
| | Young Adult | 2 | 2018 | 10517 | 0.100 |
Why?
| | Thioredoxins | 1 | 2011 | 33 | 0.100 |
Why?
| | Pilot Projects | 1 | 2016 | 1374 | 0.100 |
Why?
| | Neuroprotective Agents | 1 | 2011 | 105 | 0.090 |
Why?
| | Tacrolimus | 1 | 2011 | 143 | 0.090 |
Why?
| | Glutathione | 1 | 2011 | 303 | 0.090 |
Why?
| | Blotting, Western | 1 | 2012 | 1153 | 0.090 |
Why?
| | Mutation | 1 | 2020 | 3370 | 0.090 |
Why?
| | Clinical Competence | 1 | 2016 | 918 | 0.080 |
Why?
| | Macrophages | 1 | 2016 | 1281 | 0.080 |
Why?
| | Enzyme Inhibitors | 1 | 2012 | 758 | 0.080 |
Why?
| | Algorithms | 1 | 2016 | 1493 | 0.080 |
Why?
| | Reproducibility of Results | 1 | 2016 | 2814 | 0.080 |
Why?
| | Body Mass Index | 1 | 2015 | 1982 | 0.080 |
Why?
| | Immunohistochemistry | 1 | 2012 | 1643 | 0.080 |
Why?
| | Colorado | 1 | 2018 | 4122 | 0.080 |
Why?
| | Phenotype | 1 | 2015 | 2859 | 0.080 |
Why?
| | Immunosuppressive Agents | 1 | 2011 | 666 | 0.070 |
Why?
| | Adult | 2 | 2018 | 30817 | 0.070 |
Why?
| | Inflammation | 1 | 2015 | 2503 | 0.060 |
Why?
| | Disease Models, Animal | 3 | 2019 | 3583 | 0.050 |
Why?
| | Retrospective Studies | 1 | 2018 | 12616 | 0.050 |
Why?
| | Neurons | 1 | 2006 | 1301 | 0.040 |
Why?
| | Male | 4 | 2013 | 56127 | 0.040 |
Why?
| | Oxidative Stress | 2 | 2013 | 1096 | 0.030 |
Why?
| | Connective Tissue | 1 | 2016 | 36 | 0.030 |
Why?
| | Pelvic Organ Prolapse | 1 | 2016 | 40 | 0.030 |
Why?
| | Muscle, Smooth | 1 | 2016 | 149 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2016 | 546 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2016 | 779 | 0.030 |
Why?
| | Hemoglobin, Sickle | 1 | 2013 | 14 | 0.030 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2013 | 185 | 0.030 |
Why?
| | NF-kappa B | 1 | 2016 | 639 | 0.030 |
Why?
| | Thioredoxin Reductase 2 | 1 | 2011 | 2 | 0.030 |
Why?
| | Aldehyde Oxidoreductases | 1 | 2011 | 30 | 0.020 |
Why?
| | Statistics as Topic | 1 | 2011 | 299 | 0.020 |
Why?
| | Immunity, Innate | 1 | 2016 | 733 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2011 | 933 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2013 | 3916 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2016 | 5090 | 0.020 |
Why?
| | Apoptosis | 1 | 2011 | 2377 | 0.010 |
Why?
|
|
Hurt's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|